Literature DB >> 10762343

The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein.

A Porcella1, C Maxia, G L Gessa, L Pani.   

Abstract

We used reverse transcriptase polymerase chain reaction to detect the expression of the central and peripheral cannabinoid receptors (CB1 and CB2, respectively) mRNA, and Western blotting to show the presence of the CB1 protein in subregions of the human eye. CB2 mRNA transcripts were undetectable, while levels of CB1 mRNA were significantly expressed in the human retina (25.8 +/- 2.46%), ciliary body (210 +/- 11.55%) and iris (62.7 +/- 5.94%) when compared with those of the normalizing reference gene beta2 microglobulin. The CB1 gene encodes a functional protein which is detected in its glycosylated (63 kDa) and unglycosylated (54 kDa) form in the same areas by a specific purified antibody raised against the amino terminus (residues 1-77) of the CB1 receptor. These results further support the proposed role of the CB1 receptor in controlling intraocular pressure, helping to explain the antiglaucoma properties of marijuana.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762343     DOI: 10.1046/j.1460-9568.2000.01027.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  30 in total

1.  Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABA(B) receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina.

Authors:  Juha R Savinainen; Jarmo T Laitinen
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

Review 2.  Synaptic transmission at retinal ribbon synapses.

Authors:  Ruth Heidelberger; Wallace B Thoreson; Paul Witkovsky
Journal:  Prog Retin Eye Res       Date:  2005-11       Impact factor: 21.198

3.  Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.

Authors:  Tushar Hingorani; Waseem Gul; Mahmoud Elsohly; Michael A Repka; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2011-10-11       Impact factor: 3.534

4.  Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

Authors:  Shakiru O Alapafuja; Michael S Malamas; Vidyanand Shukla; Alexander Zvonok; Sally Miller; Laura Daily; Girija Rajarshi; Christina Yume Miyabe; Honrao Chandrashekhar; JodiAnne Wood; Sergiy Tyukhtenko; Alex Straiker; Alexandros Makriyannis
Journal:  Bioorg Med Chem       Date:  2018-11-03       Impact factor: 3.641

Review 5.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

6.  Ocular Disposition of ∆8-Tetrahydrocannabinol from Various Topical Ophthalmic Formulations.

Authors:  Nagendra S Punyamurthula; Goutham R Adelli; Waseem Gul; Michael A Repka; Mahmoud A ElSohly; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2016-11-30       Impact factor: 3.246

7.  Architecture of cannabinoid signaling in mouse retina.

Authors:  Sherry Shu-Jung Hu; Andy Arnold; Jacqueline M Hutchens; Josh Radicke; Benjamin F Cravatt; Jim Wager-Miller; Ken Mackie; Alex Straiker
Journal:  J Comp Neurol       Date:  2010-09-15       Impact factor: 3.215

8.  A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway.

Authors:  Chanjuan Shi; Anna Szczesniak; Lucy Mao; Christine Jollimore; Miguel Coca-Prados; Orlando Hung; Melanie E M Kelly
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

9.  Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.

Authors:  B T McIntosh; B Hudson; S Yegorova; C A B Jollimore; M E M Kelly
Journal:  Br J Pharmacol       Date:  2007-10-08       Impact factor: 8.739

10.  Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs.

Authors:  Erika Cottone; Valentina Pomatto; Fulvio Cerri; Ezio Campantico; Ken Mackie; Massimiliano Delpero; Alda Guastalla; Claudio Dati; Patrizia Bovolin; Maria Fosca Franzoni
Journal:  Fish Physiol Biochem       Date:  2013-03-17       Impact factor: 2.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.